New drug seeks to help pancreatic cancer patients at Memorial Regional Hospital

Memorial Regional Hospital in Hollywood is using an experimental drug, Daraxonrasib, to treat pancreatic cancer patients. Russell Reed, a Stage 2B pancreatic cancer patient, and his wife Marnie are advocating for access to the drug, which has shown extended survival times in trials compared to chemotherapy. Dr. Jesus Fabregas from the Memorial Cancer Institute highlights the drug's potential to improve quality of life by targeting a protein linked to cancer growth.